Aradigm Corporation;The Regents of The University of California
发明人:
Igor Gonda,Homer A. Boushey
申请号：
US14625044
公开号：
US09857387B2
申请日:
2015.02.18
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention provides a method of detecting abnormal entry of gastrointestinal contents into the respiratory tract of a patient. The method comprises orally administering to a subject formulation comprising a detectable label that is not absorbed from the gastrointestinal tract but can be absorbed from the respiratory tract. The extent of the gastrointestinal contents entering the respiratory tract can be estimated by measuring the level of the detectable label in a body fluid, e.g., blood or urine.
